Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Elicio Therapeutics, Inc. | 103,225 | reported | 03 Jun 2025 | tx 9+10,262,239−3,442,341 |
| Immix Biopharma, Inc. | 6,250 | reported | 22 May 2026 | tx 6+121,420 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 22 May 2026 | GRANT_AWARD | Immix Biopharma, Inc. | 6,250 | 0.00 USD | |
| 22 May 2026 | GRANT_AWARD | Immix Biopharma, Inc. | 12,500 | 0.00 USD | deriv |
| 20 Jun 2025 | GRANT_AWARD | Immix Biopharma, Inc. | 33,000 | 0.00 USD | deriv |
| 03 Jun 2025 | GRANT_AWARD | Elicio Therapeutics, Inc. | 103,225 | 0.00 USD | deriv |
| 19 May 2025 | GRANT_AWARD | Elicio Therapeutics, Inc. | 7,900 | 0.00 USD | deriv |
| 05 Mar 2025 | CONVERSION | Elicio Therapeutics, Inc. | 3,500,573 | 5.81 USD | |
| 05 Mar 2025 | CONVERSION | Elicio Therapeutics, Inc. | 3,442,341 | 5.81 USD | deriv |
| 21 Nov 2024 | GRANT_AWARD | Elicio Therapeutics, Inc. | 4,100 | 0.00 USD | deriv |
| 12 Aug 2024 | PURCHASE | Elicio Therapeutics, Inc. | 3,442,341 | 5.81 USD | deriv |
| 28 Jun 2024 | PURCHASE | Elicio Therapeutics, Inc. | 1,600,000 | 0.00 USD | deriv |
| 28 Jun 2024 | PURCHASE | Elicio Therapeutics, Inc. | 1,600,000 | 4.99 USD | deriv |
| 11 Jun 2024 | GRANT_AWARD | Immix Biopharma, Inc. | 33,000 | 0.00 USD | deriv |
| 28 Dec 2023 | GRANT_AWARD | Elicio Therapeutics, Inc. | 4,100 | 0.00 USD | deriv |
| 22 Aug 2023 | GRANT_AWARD | Immix Biopharma, Inc. | 20,000 | 0.00 USD | deriv |
| 22 Aug 2023 | GRANT_AWARD | Immix Biopharma, Inc. | 16,670 | 0.00 USD | deriv |